Cargando…

470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E., Sader, Helio S., Flamm, Robert K., Farrell, David J., Jones, Ronald N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782286/
http://dx.doi.org/10.1093/ofid/ofu052.336
_version_ 1783295158704406528
author Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
author_facet Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
author_sort Mendes, Rodrigo E.
collection PubMed
description
format Online
Article
Text
id pubmed-5782286
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57822862018-03-01 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013) Mendes, Rodrigo E. Sader, Helio S. Flamm, Robert K. Farrell, David J. Jones, Ronald N. Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782286/ http://dx.doi.org/10.1093/ofid/ofu052.336 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Mendes, Rodrigo E.
Sader, Helio S.
Flamm, Robert K.
Farrell, David J.
Jones, Ronald N.
470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title_full 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title_fullStr 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title_full_unstemmed 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title_short 470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
title_sort 470 oritavancin activity against gram-positive clinical isolates responsible for documented skin and skin structure infections in usa and european hospitals (2012-2013)
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782286/
http://dx.doi.org/10.1093/ofid/ofu052.336
work_keys_str_mv AT mendesrodrigoe 470oritavancinactivityagainstgrampositiveclinicalisolatesresponsiblefordocumentedskinandskinstructureinfectionsinusaandeuropeanhospitals20122013
AT saderhelios 470oritavancinactivityagainstgrampositiveclinicalisolatesresponsiblefordocumentedskinandskinstructureinfectionsinusaandeuropeanhospitals20122013
AT flammrobertk 470oritavancinactivityagainstgrampositiveclinicalisolatesresponsiblefordocumentedskinandskinstructureinfectionsinusaandeuropeanhospitals20122013
AT farrelldavidj 470oritavancinactivityagainstgrampositiveclinicalisolatesresponsiblefordocumentedskinandskinstructureinfectionsinusaandeuropeanhospitals20122013
AT jonesronaldn 470oritavancinactivityagainstgrampositiveclinicalisolatesresponsiblefordocumentedskinandskinstructureinfectionsinusaandeuropeanhospitals20122013